• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝 X 受体激活通过 LXRβ 重定位抑制 Wnt 信号通路减少胃癌细胞增殖。

Liver X receptor activation reduces gastric cancer cell proliferation by suppressing Wnt signalling via LXRβ relocalization.

机构信息

Institute of Life Sciences, Jiangsu University, Zhenjiang, China.

The Fourth Affiliated Hospital of Jiangsu University, Zhenjiang, China.

出版信息

J Cell Mol Med. 2019 Feb;23(2):789-797. doi: 10.1111/jcmm.13974. Epub 2018 Oct 19.

DOI:10.1111/jcmm.13974
PMID:30338932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6349166/
Abstract

Liver X receptors (LXRs) are involved in various diseases associated with lipid disorders, and in regulating cancer cell proliferation. However, the underlying molecular mechanisms, especially those in gastric cancer (GC) remain to be clarified. In this study, immunohistochemistry analysis revealed that LXRβ was mainly expressed in GC tissue, with less expression in adjacent normal tissues. The LXRβ agonist T0901317 efficiently suppressed the proliferation and colony formation of various GC cell lines. We further showed that LXRβ translocated from the cytoplasm to the nucleus when activated by T0901317. LXRβ nuclear localization suppressed the activation of Wnt signalling and decreased the expression of target genes such as MYC, BMP4, and MMP7 through binding to their promoters. Moreover, we demonstrated that the LXR agonist efficiently suppressed GC tumour growth in a nude mouse xenograft model. Taken together, these results revealed that LXRβ agonist inhibited GC cells proliferation by suppressing Wnt signalling via LXRβ relocalization. The results strongly suggest that LXRβ could be a promising target in GC therapy.

摘要

肝 X 受体 (LXRs) 参与与脂质紊乱相关的各种疾病,并调节癌细胞增殖。然而,其潜在的分子机制,特别是在胃癌 (GC) 中的机制仍有待阐明。在这项研究中,免疫组织化学分析显示 LXRβ 主要在 GC 组织中表达,在相邻的正常组织中表达较少。LXRβ 激动剂 T0901317 有效地抑制了各种 GC 细胞系的增殖和集落形成。我们进一步表明,当被 T0901317 激活时,LXRβ 从细胞质转位到细胞核。LXRβ 的核定位通过与启动子结合抑制 Wnt 信号的激活,并降低靶基因如 MYC、BMP4 和 MMP7 的表达。此外,我们证明 LXR 激动剂在裸鼠异种移植模型中有效地抑制了 GC 肿瘤的生长。总之,这些结果表明 LXRβ 激动剂通过 LXRβ 重定位抑制 Wnt 信号抑制 GC 细胞增殖。这些结果强烈表明 LXRβ 可能成为 GC 治疗的一个有前途的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/274c/6349166/b06e34eb35ca/JCMM-23-789-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/274c/6349166/a8a5eea14119/JCMM-23-789-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/274c/6349166/29ca1d1be31b/JCMM-23-789-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/274c/6349166/b308c60e1186/JCMM-23-789-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/274c/6349166/6bb9a4be44e5/JCMM-23-789-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/274c/6349166/b06e34eb35ca/JCMM-23-789-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/274c/6349166/a8a5eea14119/JCMM-23-789-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/274c/6349166/29ca1d1be31b/JCMM-23-789-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/274c/6349166/b308c60e1186/JCMM-23-789-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/274c/6349166/6bb9a4be44e5/JCMM-23-789-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/274c/6349166/b06e34eb35ca/JCMM-23-789-g005.jpg

相似文献

1
Liver X receptor activation reduces gastric cancer cell proliferation by suppressing Wnt signalling via LXRβ relocalization.肝 X 受体激活通过 LXRβ 重定位抑制 Wnt 信号通路减少胃癌细胞增殖。
J Cell Mol Med. 2019 Feb;23(2):789-797. doi: 10.1111/jcmm.13974. Epub 2018 Oct 19.
2
Liver X receptors agonist T0901317 downregulates matrix metalloproteinase-9 expression in non-small-cell lung cancer by repressing nuclear factor-κB.肝脏X受体激动剂T0901317通过抑制核因子κB下调非小细胞肺癌中基质金属蛋白酶-9的表达。
Anticancer Drugs. 2017 Oct;28(9):952-958. doi: 10.1097/CAD.0000000000000532.
3
Activation of LXRβ inhibits proliferation, promotes apoptosis, and increases chemosensitivity of gastric cancer cells by upregulating the expression of ATF4.LXRβ 的激活通过上调 ATF4 的表达抑制胃癌细胞的增殖、促进凋亡,并增加其化疗敏感性。
J Cell Biochem. 2019 Sep;120(9):14336-14347. doi: 10.1002/jcb.28558. Epub 2019 Jun 18.
4
LXRβ Activation Inhibits the Proliferation of Small-cell Lung Cancer Cells by Depleting Cellular Cholesterol.LXRβ 激活通过耗竭细胞胆固醇抑制小细胞肺癌细胞的增殖。
Anticancer Res. 2022 Jun;42(6):2923-2930. doi: 10.21873/anticanres.15774.
5
1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulators.7-脱氢胆固醇的1α-羟基衍生物是选择性肝脏X受体调节剂。
J Steroid Biochem Mol Biol. 2017 Sep;172:136-148. doi: 10.1016/j.jsbmb.2017.07.014. Epub 2017 Jul 20.
6
Suppression of beta-catenin signaling by liver X receptor ligands.肝脏X受体配体对β-连环蛋白信号通路的抑制作用。
Biochem Pharmacol. 2009 Jan 15;77(2):186-95. doi: 10.1016/j.bcp.2008.10.007. Epub 2008 Oct 15.
7
Liver X receptor activation inhibits PC-3 prostate cancer cells via the beta-catenin pathway.肝脏X受体激活通过β-连环蛋白途径抑制PC-3前列腺癌细胞。
Pathol Res Pract. 2017 Mar;213(3):267-270. doi: 10.1016/j.prp.2016.04.013. Epub 2016 May 12.
8
The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells.宿主防御肽 LL-37 通过抑制蛋白酶体激活胃癌细胞中的肿瘤抑制性骨形态发生蛋白信号。
J Cell Physiol. 2010 Apr;223(1):178-86. doi: 10.1002/jcp.22026.
9
Tumor Suppressor Gene XEDAR Promotes Differentiation and Suppresses Proliferation and Migration of Gastric Cancer Cells Through Upregulating the RELA/LXRα Axis and Deactivating the Wnt/β-Catenin Pathway.抑癌基因 XEDAR 通过上调 RELA/LXRα 轴和失活 Wnt/β-连环蛋白通路促进胃癌细胞的分化,抑制其增殖和迁移。
Cell Transplant. 2021 Jan-Dec;30:963689721996346. doi: 10.1177/0963689721996346.
10
Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis.核 MYH9 诱导 CTNNB1 转录,受星形孢菌素靶向调控,促进胃癌细胞抗失巢凋亡和转移。
Theranostics. 2020 Jun 12;10(17):7545-7560. doi: 10.7150/thno.46001. eCollection 2020.

引用本文的文献

1
The Cytotoxicity of 27-Hydroxycholesterol in MCF-7 and MDA-MB-231.27-羟基胆固醇对MCF-7和MDA-MB-231细胞的细胞毒性
Adv Biomed Res. 2023 Oct 28;12:246. doi: 10.4103/abr.abr_13_23. eCollection 2023.
2
Unraveling the Anticancer Potential of Statins: Mechanisms and Clinical Significance.解析他汀类药物的抗癌潜力:作用机制与临床意义
Cancers (Basel). 2023 Sep 29;15(19):4787. doi: 10.3390/cancers15194787.
3
The Role of Lipid Metabolism in Gastric Cancer.脂质代谢在胃癌中的作用。

本文引用的文献

1
Treatment of colon cancer with liver X receptor agonists induces immunogenic cell death.用肝 X 受体激动剂治疗结肠癌会诱导免疫原性细胞死亡。
Mol Carcinog. 2018 Jul;57(7):903-910. doi: 10.1002/mc.22811. Epub 2018 Apr 6.
2
Liver X receptors as potential targets for cancer therapeutics.肝脏X受体作为癌症治疗的潜在靶点。
Oncol Lett. 2017 Dec;14(6):7676-7680. doi: 10.3892/ol.2017.7259. Epub 2017 Oct 23.
3
Predictive relevance of PD-L1 expression with pre-existing TILs in gastric cancer.PD-L1表达与胃癌中预先存在的肿瘤浸润淋巴细胞的预测相关性。
Front Oncol. 2022 Jun 15;12:916661. doi: 10.3389/fonc.2022.916661. eCollection 2022.
4
Genome-Scale Metabolic Model Analysis of Metabolic Differences between Lauren Diffuse and Intestinal Subtypes in Gastric Cancer.胃癌中Lauren弥漫型和肠型亚型代谢差异的全基因组规模代谢模型分析
Cancers (Basel). 2022 May 9;14(9):2340. doi: 10.3390/cancers14092340.
5
Aberrant lipid metabolism reprogramming and immune microenvironment for gastric cancer: a literature review.胃癌的异常脂质代谢重编程与免疫微环境:文献综述
Transl Cancer Res. 2021 Aug;10(8):3829-3842. doi: 10.21037/tcr-21-655.
6
Statins: a repurposed drug to fight cancer.他汀类药物:一种用于抗癌的再利用药物。
J Exp Clin Cancer Res. 2021 Jul 24;40(1):241. doi: 10.1186/s13046-021-02041-2.
7
T0901317, an Agonist of Liver X Receptors, Attenuates Neuronal Apoptosis in Early Brain Injury after Subarachnoid Hemorrhage in Rats via Liver X Receptors/Interferon Regulatory Factor/P53 Upregulated Modulator of Apoptosis/Dynamin-1-Like Protein Pathway.T0901317,肝 X 受体激动剂,通过肝 X 受体/干扰素调节因子/P53 上调凋亡调节因子/动力蛋白-1 样蛋白通路减轻蛛网膜下腔出血后大鼠早期脑损伤中的神经元凋亡。
Oxid Med Cell Longev. 2021 May 28;2021:8849131. doi: 10.1155/2021/8849131. eCollection 2021.
8
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.细胞质 LXR 表达是早期原发性乳腺癌患者预后不良的独立标志物。
J Cancer Res Clin Oncol. 2021 Sep;147(9):2535-2544. doi: 10.1007/s00432-021-03670-y. Epub 2021 Jun 3.
9
The Pivotal Role of the Dysregulation of Cholesterol Homeostasis in Cancer: Implications for Therapeutic Targets.胆固醇稳态失调在癌症中的关键作用:对治疗靶点的启示
Cancers (Basel). 2020 May 29;12(6):1410. doi: 10.3390/cancers12061410.
10
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution.新型治疗方法和目标在肾癌评估下:等待革命。
Clin Drug Investig. 2019 Jun;39(6):503-519. doi: 10.1007/s40261-019-00773-w.
Oncotarget. 2017 Oct 26;8(59):99372-99381. doi: 10.18632/oncotarget.22079. eCollection 2017 Nov 21.
4
Liver X receptor activation inhibits PC-3 prostate cancer cells via the beta-catenin pathway.肝脏X受体激活通过β-连环蛋白途径抑制PC-3前列腺癌细胞。
Pathol Res Pract. 2017 Mar;213(3):267-270. doi: 10.1016/j.prp.2016.04.013. Epub 2016 May 12.
5
The emerging roles of liver X receptors and their ligands in cancer.肝脏X受体及其配体在癌症中的新作用。
Expert Opin Ther Targets. 2016;20(1):61-71. doi: 10.1517/14728222.2015.1081169. Epub 2015 Aug 26.
6
Liver X receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localization.肝脏X受体配体在结肠癌细胞而非正常结肠上皮细胞中的细胞毒性取决于LXRβ的亚细胞定位。
Oncotarget. 2015 Sep 29;6(29):26651-62. doi: 10.18632/oncotarget.5791.
7
Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.Wnt/β-连环蛋白信号通路在胃癌中的作用:深入文献综述
World J Exp Med. 2015 May 20;5(2):84-102. doi: 10.5493/wjem.v5.i2.84.
8
Targeting liver X receptors in cancer therapeutics.靶向治疗癌症的肝 X 受体。
Nat Rev Cancer. 2015 Apr;15(4):216-24. doi: 10.1038/nrc3912. Epub 2015 Mar 19.
9
Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells.肝脏X受体配体在胰腺导管腺癌细胞中的抗增殖作用及机制
PLoS One. 2014 Sep 3;9(9):e106289. doi: 10.1371/journal.pone.0106289. eCollection 2014.
10
Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells.肝脏X受体β激活诱导人源和鼠源结肠癌细胞发生焦亡。
Cell Death Differ. 2014 Dec;21(12):1914-24. doi: 10.1038/cdd.2014.117. Epub 2014 Aug 15.